Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
2
Bullish
9
Bearish
32
Neutral
2
Bullish
12
Bearish
29
Neutral
0
Bullish
3
Bearish
3
Neutral
2
Bullish
9
Bearish
3
Neutral
2
Bullish
9
Bearish
29
Neutral
0
Bullish
3
Bearish
29
Neutral
0
Bullish
3
Bearish
29
Neutral
0
Bullish
3
Upcoming Result Date: Oct 29, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Discovery themes featuring this stock
Aether Industries is an Indian specialty chemical manufacturer focused on advanced intermediates and differentiated chemistries across CRAMS, contract exclusive manufacturing (CEM), and large scale manufacturing; it operates multiple manufacturing sites and a large R&D team to serve pharmaceuticals, agrochemicals, oil & gas, and material science customers.
In Q1 FY27 consolidated revenue reached INR3,266 million, up 27% year-on-year, with EBITDA of INR1,028 million and a 31% margin, while PAT rose 33% to INR627 million; management reported disciplined balance sheet management but higher inventories tied to strategic raw material positioning and ramping new sites.
Management is executing a large capacity build: Magnum (Site 5) in Panoli is being developed as a multi-block mega site with total investment of INR2,200–2,300 crores and phased commissioning, intended to produce low-volume, high-value specialty monomers for electronics, oil & gas and other high-performance markets.
Strategically, Aether is shifting mix toward higher-margin CEM and CRAMS where EBITDA margins are reported north of 28–30%, targeting these models to contribute over 70% of revenue in coming years while also pursuing a multi-year exclusive R&D partnership with Dow to develop silicone platform technologies.
Operationally the company is scaling Site 3++ (ramping since February 2026), progressing a larger R&D campus with 15 new labs and 160 fume hoods for FY2028, and reporting strong customer audits and onboardings that validate the industrialization of complex chemistries at competitive scale.
Chemicals & Petrochemicals
Specialty Chemicals
18,767 Cr
Low Risk
79.8
35.0
3.1
7.6
1,813.00
723.15
Sales CAGR
Profit CAGR
ROE
ROCE
Aether Industries Ltd (AETHER) is currently trading at 1,412.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aether Industries is an Indian specialty chemical manufacturer focused on advanced intermediates and differentiated chemistries across CRAMS, contract exclusive manufacturing (CEM), and large scale manufacturing; it operates multiple manufacturing sites and a large R&D team to serve pharmaceuticals, agrochemicals, oil & gas, and material science customers. In Q1 FY27 consolidated revenue reached INR3,266 million, up 27% year-on-year, with EBITDA of INR1,028 million and a 31% margin, while PAT rose 33% to INR627 million; management reported disciplined balance sheet management but higher inventories tied to strategic raw material positioning and ramping new sites. Management is executing a large capacity build: Magnum (Site 5) in Panoli is being developed as a multi-block mega site with total investment of INR2,200–2,300 crores and phased commissioning, intended to produce low-volume, high-value specialty monomers for electronics, oil & gas and other high-performance markets. Strategically, Aether is shifting mix toward higher-margin CEM and CRAMS where EBITDA margins are reported north of 28–30%, targeting these models to contribute over 70% of revenue in coming years while also pursuing a multi-year exclusive R&D partnership with Dow to develop silicone platform technologies. Operationally the company is scaling Site 3++ (ramping since February 2026), progressing a larger R&D campus with 15 new labs and 160 fume hoods for FY2028, and reporting strong customer audits and onboardings that validate the industrialization of complex chemistries at competitive scale.
Over the past 52 weeks, Aether Industries Ltd has traded between a low of ₹723.15 and a high of ₹1,813.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aether Industries Ltd has a market capitalization of approximately 18,767.12. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aether Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 79.79 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 18,767.12 Cr, Aether Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aether Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aether Industries Ltd is 79.79. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Aether reported consolidated net profit of ₹627.49 million in Q1FY27, up 33.6% YoY from ₹470.21 million.
The fire occurred at an external warehouse at Plot Nos. 24/9 and partially 24/10, Hojiwala Industrial Estate, Sachin, Surat.
The 10,000 crore Biopharma Shakti scheme aims to make India a biopharma hub. Aether, with its strong CRAMS and CEM segments serving the pharma industry, is well-positioned to capture demand for advanced intermediates and biologics-related chemicals.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1447.20 | 19,739 Cr | 25.20 | 3.38 | 0.52 | 9.43 | 10.74 | 9.02 | ||
1413.95 | 18,767 Cr | 79.79 | 7.64 | 0.00 | 8.94 | 10.61 | 7.35 | ||
5578.40 | 16,424 Cr | 20.86 | 2.64 | 0.54 | 11.73 | 15.82 | 9.35 | ||
427.20 | 15,496 Cr | 29.18 | 2.60 | 0.23 | 7.04 | 6.41 | 3.99 | ||
5054.00 | 15,496 Cr | 35.37 | 5.82 | 0.22 | 15.65 | 20.00 | 14.61 | ||
3069.15 | 13,285 Cr | 21.30 | 3.36 | 0.81 | 10.62 | 14.23 | 7.62 | ||
3247.35 | 12,685 Cr | 37.09 | 8.98 | 0.31 | 23.19 | 21.43 | 10.79 | ||
| Median: 7 Co. | — | 3069.15 | 15,496 Cr | 29.18 | 3.38 | 0.31 | 10.62 | 14.23 | 9.02 |
